Estrella Immunopharma, Inc. Common Stock
ESLA
XNAS
•
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market Cap
34M
Short interest (Jul 15)
0.1%
Net Short (Jul 27 ): 0.0%
Borrow Fee
13.26%
Available Shares
4M
Price Chart
Company Overview
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Company Info
Exchange:
NASDAQ
Industry:
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CIK:
0001844417
Asset Type:
CS
Market Data
Market Cap:
$33,566,697
Status:
Active
Short Interest
Current Borrow Fee
13.26%
Range: 13.26% -
13.26%
Available Shares
4M
Range: 4.2M -
4.2M
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.